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S U M M A R Y
Objective: Swine hepatitis E virus (HEV) is considered to be a new zoonotic agent due to its close genomic
resemblance to the human HEV. The aim of this study was to determine human HEV seroprevalence in
eastern Romania and to characterize circulating swine HEV sequences.
Methods: Serological investigations of human serum samples were done using a commercial ELISA kit
(MP Biomedicals). Swine faecal samples were tested to detect the HEV ORF2 sequence by nested reverse
transcription PCR.
Results: One hundred and forty-eight human serum samples were tested for anti-HEV IgG of which
22 were found to be positive. Fresh swine faeces (pools) were collected from ﬁve farms in eastern
Romania. Six out of 19 pooled samples were positive for HEV RNA. Phylogenetic analysis based on
alignment of the ORF2 sequence indicated that the Romanian swine HEV isolates belonged to genotype 3.
Conclusions: This is the ﬁrst study showing HEV to be present in Romanian pig herds and that the human
population is exposed.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
The hepatitis E virus (HEV) is a major pathogen causing acute
hepatitis in young people in developing countries where there is
poor sanitation and a high population density. HEV infection is often
asymptomatic but can induce a self-limited acute hepatitis.1
Hepatitis E has been diagnosed in industrialized countries, and it
has been demonstrated that the genomic sequence of isolated HEV
strains is most related to swine HEV prevalent in the swine
population from the same region.2 The existence of a zoonotic
reservoir has also been revealed, as the virus has been isolated from
wild and domestic animals including swine, cattle, chickens, sheep,
goats, and rodents.3,4 The ﬁrst animal virus strain was isolated from a
pig in the USA.5 Interspeciﬁc infections with hepatitis E among pigs
and non-human primates have been demonstrated experimentally,
suggesting the zoonotic nature of the disease.6* Corresponding author. Tel.: +40 74 4228143; fax: +40 232 407318.
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license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Human and swine HEV are classiﬁed in the Hepeviridae family
as a separate Orthohepevirus genus Orthohepevirus A species.7 Like
most enteric viruses, HEV is a relatively stable particle, resistant to
gastric secretions and bile salts, which explains its survival in the
intestinal environment.8 It is a small virus with a diameter
between 27 and 33 nm, with an icosahedral structure without an
envelope, which has shaped bumps visible on its surface.9 The
genome is represented by a single-stranded positive-sense RNA
molecule of 7.2 kb in length, which contains three open reading
frames (ORF).10 Four major genotypes have been deﬁned in
mammals based on ORF2 nucleotide sequence analysis.11 The four
genotypes are classiﬁed into 24 subtypes, based on a sequence
located at the 50 end of the ORF2 region, which is the best
conserved among all HEV isolates.12 Genotypes 1 and 2 do not
infect swine, while genotypes 3 and 4 are zoonotic.13
The natural transmission of swine HEV in pigs is via the
faecal–oral route. HEV infection in swine usually remains
asymptomatic. HEV replication has been demonstrated to occur
in the liver and in the intestines.14 Viraemia is transient and lasts
1 to 2 weeks. In infected pigs, faecal virus shedding may persist
for up to 7 weeks.15 Serological studies reveal a worldwideciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Table 1
Results of the serological study on human sera in 2011
Patient
age, years
Number
of samples
tested
Anti-HEV
IgG-positive
samples
Seroprevalence
(%)
95% CI
Group 1 9–20 11 0 0% 0
Group 2 21–40 28 8 28.6% 11.8–45.3
Group 3 41–62 31 4 12.9% 1.1–24.7
Total 70 12 17.1% 8.3–26
CI, conﬁdence interval.
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from 15% to 75%.16–18 In Europe, HEV has been detected in swine
in several countries; the isolated swine HEV has been charac-
terized as genotype 319 and 4.20 In Spain, HEV RNA detected in
slaughterhouse sewage presented 92–94% nucleotide similarity
with virus strains detected in humans.21 The prevalence of swine
HEV in France was estimated at 31% at the individual pig level
and 65% at the farm level.22 In the Netherlands, 97 pig farms were
screened in 2005 and the prevalence rate of swine HEV was
estimated at 55%.23 Investigations of domestic swine in Hungary
detected HEV in 39% of the pig farms involved.24
The purpose of this investigation was to assess the HEV
seroprevalence in human samples and to detect the presence of
swine HEV RNA in farm pigs from Romania, with genetic
characterization and phylogenetic analysis.
2. Materials and methods
2.1. Sample collection
Human serum from anonymous donors was provided by
hospitals in the North-eastern Region of Romania. The donors
were undergoing routine haematological tests and had no hepatitis
symptomatology. Serum from a total of 148 people aged between
10 and 90 years was evaluated between 2011 and 2012.
Pig stool samples (n = 19) were collected from ﬁve swine farms
in the eastern part of Romania in 2009 and 2010. Faecal pools were
sampled from shelters where the 2- to 4-month-old pigs were
housed. All samples were transported at refrigeration temperature
and stored at 80 8C until testing.
2.2. Anti-HEV serology
Tests for anti-HEV immunoglobulin (Ig) G were performed using a
commercial ELISA kit (MP Biomedicals; catalogue number
0721150096T) in accordance with the manufacturer’s instructions.
This assay uses three recombinant polypeptides derived from the 30
end of ORF2 (42 amino acids) and ORF3 (33 amino acids) from Burmese
and Mexican prototype sequences (genotypes 1 and 2, respectively).
For each determination, positive and negative controls, provided with
the kit, were used. The cut-off value was calculated as 0.500 plus the
mean absorbance of the non-reactive controls. IgG-reactive samples
were retested using the same commercial kit.
2.3. Processing of stool samples
Pooled samples were resuspended in 10% calcium- and magne-
sium-free phosphate-buffered saline and centrifuged at 3000 rpm.
2.4. RNA extraction and nested RT-PCR
The RNA extraction was performed from 200 ml stool suspen-
sion supernatant using the QIAamp Viral RNA Mini Kit (Qiagen;
catalogue number 52904). The extracted RNAs were stored at
80 8C until tested. Reverse transcription was performed using a
random hexamer primer (Promega; catalogue number C1181).
For the detection of HEV RNA, a nested RT-PCR was performed
using the degenerate primers.13 All samples were tested for HEV
RNA, targeting an ORF2 348-bp fragment. For the nested RT-PCR
assay, two sets of primers were used: external primer set 3156N
(5663 to 5684) and 3157N (6371 to 6393), and internal primer set
3158N (5948 to 5969) and 3159N (6274 to 6295). Negative and
positive controls were included in each set of PCRs. Negative
control (ultrapure water) was included in every reverse transcrip-
tion, ﬁrst PCR, and nested PCR. An extract from a positive HEV
genotype 3 swine faecal sample was used as positive control.The PCR parameters for the ﬁrst-round PCR with primers 3156N
and 3157N included a denaturation step at 94 8C for 1 min,
followed by 30 cycles of denaturation for 30 s at 94 8C, annealing
for 30 s at 52 8C, extension for 30 s at 72 8C, and 10 cycles of
denaturation for 30 s at 94 8C, annealing for 30 s at 40 8C, extension
for 30 s at 72 8C, followed by a ﬁnal incubation at 72 8C for 5 min.
At the end of the ﬁrst-round PCR, 5 ml of the ampliﬁcation
product and an internal primer set were used to prepare a 50-ml
reaction mix for the second-round PCR. Ten microlitres of DNA
were analysed by agarose gel electrophoresis.
2.5. Nucleotide sequencing and sequence analyses
The ampliﬁed 348-bp fragments were excised from the gel and
puriﬁed using the Wizard SV Gel and PCR Clean-Up System
(Promega; catalogue number A9281). The puriﬁed products were
directly sequenced for both strands with nested PCR primers using
the CEQ 8000 Genetic Analysis System and dye-labelled dideoxy
termination method (DTCS QuickStart sequencing reagent; Beck-
man Coulter, Fullerton, CA, USA).
Individual sequences were proofread and edited using CEQ
8000 software (Beckman Coulter), and merged into composite
sequences with SeqMan software (Lasergene v. 7; DNASTAR Inc.,
Madison, WI, USA). Different sequences were used to root the
phylogeny and were chosen as the best hits to our sequences in
GenBank. Phylogenetic inference was conducted for the combined
concatenated dataset. jModelTest version 2.025 was used to infer
the best-ﬁt model of evolution, based on hierarchical log-
likelihood ratio tests comparing successively complex models.
The evolutionary history was inferred using the maximum
likelihood method based on the generalized time-reversible model
(GTR+G). The tree topology search was done using the Best of NNIs
and SPRs algorithm, over 100 bootstrapped replications of the
dataset. The analysis involved 260 nucleotide sequences. Evolu-
tionary analyses were conducted in PhyML v3.0,26 run on the
Phylemon 2.0 platform.27
3. Results
3.1. Serological results
Out of 148 human sera tested, 22 were positive for anti-HEV
IgG. In sera analysed in 2011 (ﬁrst study) a 17.14% seroprevalence
(12/70) was estimated, whereas in 2012 (second study) a 12.82%
seroprevalence (10/78) was recorded (Tables 1–3). Anti-HEV IgG
antibody in subjects without clinical signs of hepatitis was used as
an epidemiological tool to measure exposure to this virus. Our
results revealed that HEV infections in the eastern area of Romania
affect middle-aged adults.
3.2. Swine HEV detection
Faecal samples (19 pools) collected from ﬁve swine farms with
pigs aged between 2 and 4 months were subsequently analysed by
RT-PCR to detect the presence of HEV. The analysis of nested PCR
Table 2
Results of the serological study on human sera in 2012: distribution of the tested
sera by patient gender
Patient
gender
No. of tested
samples
Anti-HEV
IgG-positive
samples
Percent of
positivity (%)
Female 38 6 15.78%
Male 40 4 10%
Total 78 10 12.82%
Table 3
Results of the serological study on human sera in 2012: distribution of the tested
sera by patient age
Patient
age, years
Number
of samples
tested
Anti-HEV
IgG-positive
samples
Seroprevalence
(%)
95% CI
Group 1 18–45 32 2 6.25% 2.1–14.6
Group 2 46–65 25 7 28% 10.4–45.6
Group 3 66–90 21 1 4.76% 4.3–13.9
Total 78 10 12.82% 5.4–20.2
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was detected in pooled samples collected from pigs of different
ages: 2.5 months old (farms B and E), 3 months old (farms C and A),
and 4 months old (farm D). To characterize the viral strains
circulating in the farm-pig populations, two of the positive PCR
products were sequenced and analysed. A 347-nucleotide se-
quence (roEF5; GenBank accession number KM058114) and a 341-
nucleotide sequence (roFPR4, GenBank accession number
KM042904) were obtained.
3.3. Phylogenetic analysis
The two Romanian sequences were found to be distributed in
different clades. According to the nucleotide sequence similarities
analysis there was a 16.2% difference between the two newly
identiﬁed swine HEV sequences.
4. Discussion
Autochthonous HEV infection, caused by genotype 3, is recog-
nized as an emerging infectious disease in developed countries. Our
previous investigation on HEV infection in eastern Romania revealed
an anti-HEV IgG prevalence of 12% (3/25) in patients diagnosed withTable 4
Results of swine hepatitis E virus detection
Farm Pool sample Pig age, months N-PCR result
A IS1 4 Negative
IS4 3 Positive
B IS2 2.5 Positive
IS3 2 Negative
C EF1 3 Negative
EF2 3 Negative
EF3 3.5 Negative
EF4 3.5 Negative
EF5 3 Positive
EF6 3 Positive
D FPR1 3 Negative
FPR2 3 Negative
FPR3 3.5 Negative
FPR4 4 Positive
E FM1 2.5 Negative
FM2 2.5 Positive
FM3 2 Negative
FM4 2 Negative
FM5 2 Negative
N-PCR, nested PCR.hepatitis B or C,28 and a 5.9% anti-HEV IgG seroprevalence (4/67) in
the general population.29 In 2010, Voiculescu et al. reported an HEV
seroprevalence of 12.5% in the very low risk population and 13.98%
in the low risk population.30
In this study the presence of anti-HEV IgG was evaluated in
148 anonymous donors aged between 10 and 90 years. Eleven
serum samples collected from children and adolescent patients (9–
20 years old) were identiﬁed as negative for anti-HEV IgG. All
infections seem to occur among middle-aged persons. These
observations agree with the data recorded from patients with
locally acquired hepatitis E in non-endemic countries.31 The HEV
antigens used in this kit included an ORF3 antigen, making it
possible to detect a class of IgG antibody that is present early in
infection.32 The commercially available anti-HEV ELISA test (MP
Biomedicals) uses antigens derived from genotypes 1 and 2 of HEV
and may underestimate the HEV seroprevalence in non-endemic
regions where genotype 3 HEV is the most prevalent.
In various studies, the IgG antibodies have proved to persist for
2–13 years.33 The results of studies done in developed countries
have shown that seropositivity increases in linear proportion with
increasing age. In certain developed countries, the seroprevalence
of anti-HEV IgG in the general population has been shown to be
generally much higher than would be expected given the low
prevalence of acute symptomatic hepatitis E cases. The prevalence
of anti-HEV in human populations suggests the possibility of
subclinical HEV infections and/or under-diagnosis. Autochthonous
hepatitis E in developed regions is frequently misdiagnosed as
drug-induced liver injury, a common problem that occurs at an
increased frequency in elderly people.34 The prevalence of HEV IgG
antibodies in low-incidence populations in the developed world
ranges from 3.2% in central France,35 4.9% in southwest
Switzerland,36 and 16% in southwest England,31 to 21% in residents
of the USA.37 In Spain, the prevalence of IgG antibodies against
HEV, which indicates exposure to this virus, varies from 0.6% to
7.3% in the general population, reaching 19% in individuals with
risk factors such as exposure to pigs.38 Our results on random
serum samples demonstrated an overall seropositivity of 14.86%.
The age-dependent seroprevalence could only be explained by age-
dependent exposure or age-dependent susceptibility, which is
difﬁcult to consider for a food-borne pathogen.39
It has been reported that a large proportion of pigs are infected
with HEV in the world. Our previous investigations regarding
swine HEV infection in Romania consisted of serological testing for
the detection of anti-HEV IgG in farm and backyard pigs. The
immunoblot results of our investigations of farm pigs revealed
37 anti-HEV IgG-positive serum samples out of 95 tested
(38.94%).40 For the backyard pigs, we detected 34 positive serum
samples out of 69 (49.27%) tested by immunoblot.29
In this study, two swine HEV strains isolated from farm pigs in
Romania were characterized. To our knowledge, this is the ﬁrst
study to conﬁrm the presence of swine HEV in Romania. All faecal
samples were collected from swine without clinical symptoms.
Swine HEV RNA was isolated from faecal samples collected from 2-
to 4-month-old pigs. These results are similar to previously
published data, conﬁrming that HEV is circulating in all farms and
in all age groups, from weaners to fatteners, and that pigs that are
close to slaughter age can still be HEV-infected.41 Romanian swine
HEV isolates were grouped into genotype 3 by phylogenetic tree
analysis and were closely related to the swine and human HEV
isolates identiﬁed in European countries.
Analysis of the sequences (Fig. 1) revealed that, at the amino
acid level, the partial capsid protein sequence (ORF2) of strain
roEF5 presented a maximum 92% identity with a French human
isolate (GenBank accession number EU495231) and 89% identity
with a swine HEV isolate from wild boar in Germany (GenBank
accession number KF303501.1), a French human strain (GenBank
Figure 1. Phylogenetic tree analysis of the Romanian isolates of swine HEV using the maximum likelihood method based on the generalized time-reversible model. The
analysis involved 260 nucleotide sequences. Evolutionary analyses were conducted in PhyML v3.0 run on the Phylemon 2.0 platform. Human and swine HEV included for
comparison are indicated with their GenBank accession number, host, and country where the strain was isolated. The ﬁnal number included in parenthesis refers to strain
identiﬁcation from polyphyletic clades listed in the Supplementary Material.
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(GenBank accession number HM446630.1). Phylogenetic analysis
revealed that this swine HEV had 91% identity with six swine
strains isolated in Bolivia (GenBank accession numbers
JQ424439.1, JQ424440.1, JQ424437.1, JQ424442.1, JQ424441.1,
and JQ424438.1) and 90% identity with three swine strains isolated
in Japan (GenBank accession numbers AB471981.1, AB471980.1,
and AB292650.1).
Similar results were obtained for pig livers in Germany,42 where
4% of the samples tested were found to be positive for HEV.
Sequence determination and phylogenetic analysis classiﬁed the
isolate strains as HEV genotype 3. In Italy, HEV RNA was detected in
31 out of 48 pigs (64.6%).43 The virus was found at a statistically
higher rate in the 3- to 4-month-old pigs (95.0%) than in the 9- to
10-month-old ones (42.9%).
According to the nucleotide sequence phylogenetic tree of the
ORF2 region (341 nucleotides) of the other isolated strain roFPR4,
it was very closely related, presenting a maximum identity of 97%
with a human isolate from the Netherlands (GenBank accession
number JQ929109) and an identity of 93% with one human isolate
from Hungary (GenBank accession number EF530667). The se-
quence identity of the analysed ORF2 fragment within the roFPR4
and the other strains from GenBank was in the range of 91–97%.
Because of the lack of published studies describing human HEV
circulation in Romania, we used human and swine HEV isolated in
neighbouring European countries in our phylogenetic analysis.
In the Netherlands, different swine HEV strains were charac-
terized and typed as genotype 3, showing close genetic similarity
to European human strains.44 The same results were obtained in
France after comparing the genetic identity of HEV strains found in
humans and in swine.45
Our results conﬁrm that domestic pigs may represent an
important animal reservoir of HEV infection. Intensive pig farming
may have become the major ampliﬁer of the virus. In our study, we
found positive pooled faecal samples for HEV RNA at each farm.
Positive samples were detected in young pigs aged 2.5–4 months.
In conclusion, the prevalence of HEV in humans in Romania is
comparable to that in other European countries. The detection of
HEV RNA in pooled faecal samples indicates the presence of HEV in
pig farms, and swine are considered a reservoir for HEV infection in
humans. The detection of swine positive for HEV raises concerns
about the potential zoonotic transmission of this virus, either
through exposure to the environment or by consumption of
contaminated pork products.
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